NasdaqCM - Nasdaq Real Time Price USD

Gelteq Limited (GELS)

1.9000

-0.4200

(-18.10%)

At close: April 25 at 4:00:02 PM EDT

1.9001

+0.00

+(0.01%)

After hours: April 25 at 7:44:25 PM EDT

Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand

Sportsgel signs first league-wide sports deal to be the official performance gel of the preeminent pickleball tour across the Oceania regionNEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces today that its sport-focused brand Sportsgel has been named an official sponsor of the Professional Pickleball Tour an

GlobeNewswire last month

GELS
-18.10%
Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

SportsGel will feature a sports-specific range of products available for license, with first deal to launch in China in H1 2025NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces the launch of its SportsGel brand. “SportsGel has been established to eliminate the common trade-off between performance versus tas

GlobeNewswire 2 months ago

GELS
-18.10%
Gelteq Appoints Matthew Jones as Head of Sports Performance

Leading internationally-experienced sports nutritionist joins the Company’s growing team to expand its sports verticalNEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Matthew Jones as Head of Sports Performance. He will oversee the growth, outreach, and customer strategy of Gelteq’

GlobeNewswire 2 months ago

GELS
-18.10%
Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Dr. Paul Wynne as its Chief Scientific Officer (“CSO”). Gelteq co-founder and CEO Nathan Givoni stated, “We believe Dr. Wynne’s distinguished record and expertise in formulation science and drug delivery systems will be instrumental

GlobeNewswire 4 months ago

GELS
-18.10%
Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Approval grants Gelteq fast track pathway for drug and entrance into the animal pharmaceuticals spaceNEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports, and other products, announces today that the U.S. Food and Drug Administration (“FDA”) has approved its suitability pe

GlobeNewswire 4 months ago

GELS
-18.10%
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products, announces that its Co-Founders, CEO Mr. Nathan Givoni and Executive Chairman Mr. Simon Szewach, will be participating in the Benchmark Company 13th Annual Discovery Investor Conference being held on

GlobeNewswire 4 months ago

GELS
-18.10%
Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Healthy Extracts expands order after high demand for Gelteq’s collagen and Mynus sugar blocker gelsNEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products, announces its largest U.S. customer, Healthy Extracts (OTCQB:HYEX), has increased its initial purcha

GlobeNewswire 4 months ago

GELS
-18.10%
HYEX
Gelteq Announces 400,000 Units Enter into Production in November 2024

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products, announces today that in November, 400,000 units of its gel solution are entering into production. These units will fulfill orders made for clients in the U.S and Australia. Delivery is expected in January 20

GlobeNewswire 4 months ago

GELS
-18.10%
Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, announced today that it has expanded its operations in the United States with the appointment of Adam Bendell as President of U.S. Operations. Gelteq Co-Founder and CEO Nathan Givoni stated, “The appo

GlobeNewswire 5 months ago

GELS
-18.10%
Gelteq Limited Closes US$5.2 Million Initial Public Offering

NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the closing of its initial public offering of 1,300,000 ordinary shares at a public offering price of US$4.00 per share. The ordinary shares commenced trading on the Nasdaq Global Market on October 29, 2024 under the symbol “GELS.” The gross proceeds from the offerin

GlobeNewswire 5 months ago

GELS
-18.10%
Gelteq Limited Prices US$5.2 Million Initial Public Offering

Company anticipates commencement of trading on Nasdaq effective October 29, 2024 under the symbol “GELS”NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today that it has priced its initial public offering of 1,300,000 ordinary shares of the Company at a public offering price of US$4.00 per share. The shares have been ap

GlobeNewswire 5 months ago

GELS
-18.10%

Performance Overview

Return	GELS	S&P 500 (^GSPC)
YTD	-18.10%	-6.06%
1-Year	-52.50%	+9.44%
3-Year	-52.50%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Gelteq Limited (GELS)

Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand

Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

Gelteq Appoints Matthew Jones as Head of Sports Performance

Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

Gelteq Receives FDA Approval of its Suitability Petition for New Animal Drug

Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

Gelteq Announces Largest U.S. Customer Increases Initial Order by 50% to Meet Growing Market Demand

Gelteq Announces 400,000 Units Enter into Production in November 2024

Gelteq Expands Operations in United States with Appointment of Adam Bendell as President of U.S. Operations to Scale Domestic Business

Gelteq Limited Closes US$5.2 Million Initial Public Offering

Gelteq Limited Prices US$5.2 Million Initial Public Offering

Performance Overview